There is considerable evidence that drug reward and brain stimulation reward (BSR) share common neural substrates. Although it is known that exposure to drugs of abuse causes a variety of molecular changes in brain reward systems, little is known about the molecular consequences of BSR. We report that repeated exposure to rewarding stimulation of the medial forebrain bundle (MFB) selectively decreases expression of GluR1 (an AMPA receptor subunit) in the VTA, without effect on expression of several other proteins (GluR2, NMDAR1, tyrosine hydroxylase). This effect of BSR on GluR1 expression is opposite of that caused by intermittent exposure to cocaine and morphine, which are known to elevate GluR1 expression in the VTA. Considering that elevated GluR1 expression in the VTA has been associated with increased sensitivity to drug reward, the finding that BSR and drugs of abuse have opposite effects on GluR1 expression in this region may provide an explanation for why the reward-related effects of many drugs (cocaine, morphine, amphetamine, PCP, nicotine) Electrical brain stimulation, like intravenous administration of drugs of abuse, can establish arbitrary response habits (e.g., lever-pressing) in rats (see Wise 1996). Although there are many sites at which brain stimulation is rewarding, stimulation of the medial forebrain bundle (MFB) at the level of the lateral hypothalamus (LH) produces high response rates without evidence of aversive effects. Moreover, it is thought that the MFB is part of a final common path for the rewarding effects of brain stimulation at a variety of limbic sites (Wise 1996).Many drugs of abuse-including morphine, cocaine, amphetamine, phencyclidine (PCP), and nicotine-potentiate the rewarding impact of MFB stimulation (see Wise 1996). When tested in the "curve-shift" variant of the brain stimulation reward (BSR) paradigm, these drugs increase the potency of the stimulation, causing leftward shifts in the functions that relate response strength to stimulation strength (Gallistel and Freyd 1987;Frank et al. 1988). Such shifts suggest additivity between the rewarding effects of the drug and the rewarding effects of the stimulation. Conversely, agents that attenuate drug reward (dopamine or opioid antagonists) attenuate BSR on their own, and block the ability of drugs of abuse to cause leftward shifts (Gallistel and Freyd 1987;Rompré and Wise 1989 (Wise 1996). Together, these findings are often considered evidence that drug reward and BSR share common neural substrates. Repeated exposure to drugs of abuse can alter their rewarding effects in rats. Pre-exposure to amphetamine, cocaine, and morphine facilitates the ability of these drugs to establish conditioned place preferences (Lett 1989). Similarly, rats pre-exposed to amphetamine or cocaine learn more rapidly to self-administer these drugs intravenously (Piazza et al. 1990;Horger et al. 1990). These findings suggest that drug reward undergoes sensitization (reverse-tolerance) with repeated intermittent treatment. However, in curve-shift ...